Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03135236 · ClinicalTrials.gov registry record · NA

Parents as the Primary Sexuality Educators for Their Young Adults With Down Syndrome

A NA study of Down Syndrome and Parent-Child Relations, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT03135236: Completed NA study of Down Syndrome and Parent-Child Relations, sponsored by Wake Forest University Health Sciences.

NCT03135236 is a NA study of Down Syndrome and Parent-Child Relations that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 13 participants, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03135236, a NA study of Down Syndrome and Parent-Child Relations, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

By integrating sexuality and disability literatures, theories, and research methodologies, this study aims to: 1) contribute to the limited knowledge professionals have of parents as the primary sexuality educators; 2) create a resource for parents in order to be sexuality educators for their young adults with I/DD; and 3) evaluate the effectiveness of the Home B.A.S.E. for Developmental Disabilities Curriculum. In order to meet the objectives the study seeks to answer the following questions: 1. What is the effectiveness of a sexuality education workshop for parents of young adults with DS on improving the self-efficacy and attitudes around sexuality and healthy relationships for young adults with DS as well as increase the parent-child communication on sexuality topics? 2. What are parents' concerns that impact their ability to be the primary sexuality educators for their young adults with DS? It is proposed that parent confidence and comfort talking about sexuality topics with their young adult with Down syndrome will increase thereby increasing the parent-child communication as a result of this study.

Primary Outcome

A paper survey will be completed before training 1 that gathers quantitative data that will address attitudes, self-efficacy, and behaviors of the parents in attendance. The survey will also be completed at the end of training 3 and then mailed to the participant to complete 1 month after the final training. The quantitative data will be used to measure a change in the attendees' attitudes, confidence, and behaviors before and after the proposed intervention. Data will be analyzed using SPSS.

Interventions

  • BEHAVIORAL Parent training

Study Locations (1)

Illinois

  • Advocate Adult Down Syndrome Center - Park Ridge

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2017-03-06
Est. Completion 2018-06-01
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT03135236 record still lists

NCT03135236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Down Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Parent training is the first listed.

NCT03135236 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT03135236 about?

NCT03135236 is a clinical study titled "Parents as the Primary Sexuality Educators for Their Young Adults With Down Syndrome". By integrating sexuality and disability literatures, theories, and research methodologies, this study aims to: 1) contribute to the limited knowledge professionals have of parents as the primary sexuality educators; 2) create a resource for parents in order to be sexuality educators for their young ...

What is the current status of trial NCT03135236?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2017-03-06. Estimated completion is 2018-06-01.

What conditions does trial NCT03135236 study?

This clinical trial studies the following conditions: Down Syndrome, Parent-Child Relations, Intellectual Disability, Sexuality.

What interventions are being tested in trial NCT03135236?

The interventions under investigation include: Parent training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03135236?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03135236 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Down Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03135236's enrollment target sits among peer trials

13 50th of 54 higher than 5 of 54 other Down Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Down Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03135236, the US trial registry maintained by the National Library of Medicine. NCT03135236 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.